Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
Publishing timestamp: 2023-09-19 20:33:05
Summary
Eli Lilly sues medical spas, wellness clinics, and compounding pharmacies for selling unauthorized versions of their diabetes drug Mounjaro. The company is facing a shortage of the drug in the U.S. due to high demand, and is seeking court orders to block sales of counterfeit versions and monetary damages. Similar lawsuits have been filed by Novo Nordisk for their weight-loss drugs. FDA has warned about safety risks of unauthorized versions of these drugs.
Sentiment: NEGATIVE
Keywords: united states, biotechnology, health care industry, lawsuits, biotech and pharmaceuticals, breaking news, business, business news, lilly drn, pharmaceuticals, novo nordisk a/s,